A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil...

Por Fullerton, Terence, Binneman, Brendon, David, William, Delnomdedieu, Marielle, Kupiec, James, Lockwood, Peter, Mancuso, Jessica, Miceli, Jeffrey, Bell, Joanne
Publicado no Alzheimers Res Ther (2018)

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Por Galasko, Douglas, Bell, Joanne, Mancuso, Jessica Y., Kupiec, James W., Sabbagh, Marwan N., van Dyck, Christopher, Thomas, Ronald G., Aisen, Paul S.
Publicado em 2014

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheim...

Por Delnomdedieu, Marielle, Duvvuri, Sridhar, Li, David Jianjun, Atassi, Nazem, Lu, Ming, Brashear, H. Robert, Liu, Enchi, Ness, Seth, Kupiec, James W.
Publicado no Alzheimers Res Ther (2016)